Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Contacts
Financials
Funding Rounds1
Number of Funding Rounds
Money Raised
Their latest funding was raised on 17.06.2024. Their latest investor Syncona Partners LLP. Their latest round Private Equity
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors1
Number of lead investors
Number of investors
Syncona Partners LLP
Syncona Partners LLP is a healthcare company that invests in and builds global leaders in life science.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Chris Hollowood
Chris is the Chief Investment Officer of Syncona Investment Management Ltd. He is currently Chairman at five Syncona companies: NightStar Therapeutics (NASDAQ:NITE), Freeline Therapeutics, Gyroscope Therapeutics, Swan Therapeutics and Orbit Biomedical. He has been instrumental in their foundation and development including the acquisition of a gene therapy manufacturing platform from Rentschler Biotechnologie on behalf of Freeline. Previously, he was a partner of Apposite Capital LLP, a venture and growth capital healthcare investment company. Before Apposite, Chris had roles with Bioscience Managers Ltd, Neptune Investment Management Ltd and in the pharmaceutical industry. Chris holds a degree in Natural Sciences and a PhD in Organic Chemistry, both from the University of Cambridge.
current job
